A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

NCT04701203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoparathyroidism
Endocrine System Diseases
Parathyroid Diseases

Interventions

COMBINATION_PRODUCT: TransCon PTH
COMBINATION_PRODUCT: Placebo

Sponsor

Ascendis Pharma Bone Diseases A/S